Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 11:30:36 2024-05-15 EDT 5-day change 1st Jan Change
396 USD +3.08% Intraday chart for Intuitive Surgical, Inc. +4.24% +17.53%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 8.03B 10.93B Sales 2025 * 9.31B 12.67B Capitalization 136B 185B
Net income 2024 * 1.97B 2.68B Net income 2025 * 2.27B 3.09B EV / Sales 2024 * 16.3 x
Net cash position 2024 * 5.19B 7.07B Net cash position 2025 * 7.75B 10.55B EV / Sales 2025 * 13.8 x
P/E ratio 2024 *
69.4 x
P/E ratio 2025 *
60.6 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.08%
1 week+4.24%
Current month+6.98%
1 month+5.07%
3 months+4.30%
6 months+35.22%
Current year+17.53%
More quotes
1 week
379.67
Extreme 379.67
396.50
1 month
364.17
Extreme 364.17
396.50
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
40.27
Extreme 40.27
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-05-15 396.2 +3.12% 309 588
24-05-14 384.2 +0.87% 913,529
24-05-13 380.9 -1.51% 1,070,927
24-05-10 386.7 +0.32% 853,114
24-05-09 385.4 +1.34% 882,194

Delayed Quote Nasdaq, May 15, 2024 at 11:15 am

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
384.2 USD
Average target price
420.4 USD
Spread / Average Target
+9.42%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW